SELLAS Life Sciences Group, Inc.
Ticker: 1390478
P/L Snapshot
Q1 FY22 · consolidated
vs Q1 FY22·vs Q1 FY21
Revenue
1.00
+0.0%-82.5%
Expenditure
17.74
+0.0%+123.1%
Net Profit
-16.74
+0.0%-597.5%
OPM %
-100.00%
-60.61pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingSLS
202624Jun
Board Meeting
Amendments to compensatory arrangements for Dr. Angelos Ster…
SEC Filing ↗ Board MeetingSLS
202616Jun
Board Meeting
Results of the Annual Meeting of Stockholders, including the…
SEC Filing ↗